Press Releases
October 31, 2006
Debiopharm presents new data confirming anti-HCV activity of cyclophilin inhibitor for Debio-025
February 9, 2006
Debiopharm S.A. presented results of a double-blind placebo-controlled study on first-in-class Debio-025 in HIV-1-infected subjects
October 6, 2004
New Data presented on Debiopharm´s Debio-025 at the 11th International Symposium on Hepatits C virus and related viruses